The company will use the funds to advance its brain shuttle platform that delivers RNAi therapies across the blood-brain ...

The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved ...

Also, Omniscient Neurotechnology has received $14 million in government-backed funding to scale its AI-based brain mapping ...

A federal jury found that Medtronic, which plans to appeal the ruling, unlawfully monopolized the bipolar surgical device ...

The company was granted a preliminary injunction blocking U.S. sales of an alleged copycat fitness tracker by Chinese company ...

Dr. Guido Giunti highlights his upcoming HIMSS26 talk that will encourage attendees to ask sharper questions about AI and ...

The company will use the funding for research and development, to launch new agentic AI tools across multiple modalities, and ...

The acquisition allows Sword to scale its presence in the U.S. and bring its physical therapy platform to the German market.

Sergio Calvo, general manager of theranostics at GE HealthCare, joins MobiHealthNews to discuss how combining molecular ...

Sergio Calvo, general manager of theranostics at GE HealthCare, discusses the organization's use of theranostics in cancer care and how the technology combines targeted therapy with diagnostic imaging ...

The partnership allows individuals to access an at-home preventive health test and, if needed, connect to One Medical’s ...

Chethan Sarabu, director of clinical innovation for the health tech hub at Cornell Tech, previews his HIMSS26 talk on AI’s ...